BPC-157 + TB-500 (Wolverine stack)

BPC-157 + TB-500 (Wolverine Stack)

BPC-157 + TB-500 is a research-grade peptide blend combining two widely studied compounds in preclinical science. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide with cytoprotective properties studied across multiple tissue types, while TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4) involved in actin sequestration, cell migration, and angiogenesis. Together, they are investigated for their complementary and potentially synergistic effects across multiple biological systems in preclinical models.

Mechanism of Action

BPC-157 has been studied in preclinical models for its effects on growth hormone receptor expression, nitric oxide system modulation, and VEGF-driven angiogenesis. TB-500 acts primarily by binding G-actin via its LKKTETQ domain, promoting cell motility and differentiation. The combination is a subject of interest in musculoskeletal and soft tissue preclinical research.

Research Applications

• Musculoskeletal and connective tissue biology studies
• Angiogenesis and vascular biology investigation
• Actin dynamics and cell migration research
• Synergistic peptide combination studies
• Preclinical inflammation modulation research

Specifications

• Composition: BPC-157 + TB-500 peptide blend
• Purity: ≥98%
• Form: Lyophilised powder
• Storage: -20°C
• Shelf Life: 24 months

Individual Components

Also available separately: BPC-157 and TB-500 Research Peptide. For a broader research panel, all three components plus GHK-Cu are available in the GLOW Blend.

This peptide blend is supplied as a lyophilised powder and requires reconstitution with Bacteriostatic Water prior to use.

This product is intended for legitimate laboratory and analytical research use only. Not for human use, veterinary use, or consumer use. Not for diagnostic or therapeutic purposes.